A patient with chronic kidney disease presents with elevated blood pressure, pulmonary congestion, and hyperkalemia. Which nursing intervention is most appropriate to address the hyperkalemia while maintaining hemodynamic stability?

C) Administer Kayexalate as prescribed to exchange sodium for potassium in the intestines.

A) Administer Lisinopril to lower blood pressure and indirectly reduce potassium levels.

B) Initiate a rapid infusion of normal saline to dilute serum potassium.

C) Administer Kayexalate as prescribed to exchange sodium for potassium in the intestines.

D) Increase the dosage of diuretics to enhance renal excretion of potassium.

A patient with chronic kidney disease presents with fluid overload, elevated blood pressure, hyperkalemia, and confusion. Which intervention should the nurse prioritize to stabilize the patient's condition?

B) Administer a diuretic to reduce fluid overload while monitoring renal function.

A) Increase the dose of Lisinopril to help control blood pressure.

B) Administer a diuretic to reduce fluid overload while monitoring renal function.

C) Provide a high-potassium diet to address electrolyte imbalances.

D) Delay interventions until the nephrology consult is completed.

A patient with chronic kidney disease is showing improvement in symptoms after fluid management and diuretic therapy but develops new muscle weakness and palpitations. Which nursing intervention is most appropriate to address these new symptoms?

B) Administer calcium gluconate as prescribed to address potential hypocalcemia

A) Increase the patient's fluid intake to address potential dehydration

B) Administer calcium gluconate as prescribed to address potential hypocalcemia

C) Encourage the patient to ambulate more frequently to improve muscle strength

D) Adjust the patient's oxygen therapy to improve oxygen saturation levels

A patient with chronic kidney disease presents with hypocalcemia and occasional premature ventricular contractions (PVCs). The healthcare team has decided to supplement the patient with calcium. Which intervention should the nurse prioritize to ensure patient safety during calcium supplementation?

C) Continuously monitor the patient's cardiac rhythm for changes in PVC frequency.

A) Administer calcium supplements with meals to enhance absorption.

B) Monitor the patient's renal function tests to prevent further deterioration.

C) Continuously monitor the patient's cardiac rhythm for changes in PVC frequency.

D) Educate the patient on increasing dietary phosphorus intake to balance electrolytes.

A patient is diagnosed with hypocalcemia and occasional premature ventricular contractions (PVCs). Which intervention should the nurse prioritize to address the patient's condition?

A) Administer calcium supplements as prescribed and monitor for cardiac changes.

B) Increase fluid intake to promote renal function and reduce serum creatinine levels.

C) Initiate a high-protein diet to enhance liver function and address muscle weakness.

D) Reduce diuretic dosage to prevent further electrolyte imbalances and improve kidney function.

A patient with chronic kidney disease is being treated for hypocalcemia and is now experiencing symptoms of fluid overload. The healthcare team has adjusted the patient's diuretic regimen to include a loop diuretic. What is the most important nursing intervention to monitor for potential complications associated with this treatment change?

B) Assess for signs of ototoxicity, such as tinnitus or hearing loss.

A) Monitor blood glucose levels closely.

B) Assess for signs of ototoxicity, such as tinnitus or hearing loss.

C) Evaluate for improvement in muscle strength and reduction in palpitations.

D) Check for signs of dehydration, such as dry mucous membranes and hypotension.

A patient with chronic kidney disease has been experiencing hypocalcemia and has shown improvement with calcium supplementation. Recently, they developed fluid overload due to adjustments in their treatment plan. Which nursing intervention should be prioritized to address the patient's current condition while maintaining electrolyte balance?

B) Administer the prescribed loop diuretic and monitor urine output closely.

A) Increase dietary calcium intake to further correct hypocalcemia.

B) Administer the prescribed loop diuretic and monitor urine output closely.

C) Restrict fluid intake to 1 liter per day to counteract fluid overload.

D) Discontinue calcium supplements to prevent further fluid overload.

A patient with worsening acute kidney injury (AKI) and hypokalemia is experiencing dizziness and orthostatic hypotension after an increase in diuretic dosage. Which of the following nursing interventions is most appropriate to address the patient's current condition?

C) Initiate potassium supplementation and monitor serum electrolyte levels closely.

A) Increase the diuretic dosage to manage fluid overload more aggressively.

B) Administer intravenous fluid bolus to correct orthostatic hypotension.

C) Initiate potassium supplementation and monitor serum electrolyte levels closely.

D) Encourage the patient to ambulate frequently to improve circulatory stability.

A patient with acute kidney injury (AKI) presents with increased serum creatinine levels, hypokalemia, and orthostatic hypotension after an adjusted diuretic regimen. Which nursing intervention is most appropriate to address the patient's current complications?

B) Administer potassium supplements and reassess fluid management strategies.

A) Increase the diuretic dosage to manage fluid overload effectively.

B) Administer potassium supplements and reassess fluid management strategies.

C) Encourage the patient to increase oral fluid intake to correct hypotension.

D) Maintain current treatment plan and monitor the patient for further symptoms.

| Acute Kidney Injury and Chronic Kidney Disease - Nursing Case Study

Pathophysiology

• Primary mechanism (Acute Kidney Injury): Sudden reduction in kidney function often due to decreased blood flow (prerenal), direct kidney damage (intrarenal), or obstruction of urine flow (postrenal), leading to rapid accumulation of waste products and electrolyte imbalances.

• Primary mechanism (Chronic Kidney Disease): Progressive, irreversible loss of nephrons due to long-term conditions such as diabetes and hypertension, resulting in decreased glomerular filtration rate (GFR) and accumulation of toxins.

• Key complication: Both conditions can lead to fluid overload, hypertension, and metabolic acidosis, increasing the risk for cardiovascular disease and impacting overall patient health.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, type 2 diabetes, stage 3 chronic kidney disease

• Current medications: Lisinopril, Metformin, Furosemide

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Decreased urine output and swelling in legs

• Key symptoms: Fatigue, nausea, shortness of breath, confusion

• Vital signs: Blood pressure 160/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the nursing team conducts an initial assessment, the patient's condition reveals further insights into his deteriorating health. Upon physical examination, notable pitting edema is observed in the lower extremities, confirming fluid retention. Auscultation of the lungs reveals bilateral crackles, suggesting pulmonary congestion, likely due to fluid overload from the compromised kidney function. The patient's JVP is elevated, which is consistent with volume overload. Laboratory tests are expedited, and initial results show elevated serum creatinine and blood urea nitrogen levels, indicating acute exacerbation of his chronic kidney disease. Electrolyte imbalances are evident, with hyperkalemia and mild hyponatremia, reflecting the kidneys' inability to maintain electrolyte homeostasis.

The nursing team monitors the patient's vital signs closely, noting a continued increase in blood pressure to 165/100 mmHg and persistent tachycardia with a heart rate of 110 bpm. Oxygen saturation has dropped further to 90% on room air, prompting the initiation of supplemental oxygen therapy. The patient's level of confusion has worsened, raising concerns about possible uremic encephalopathy. These findings necessitate a nephrology consult and the adjustment of current medications, particularly addressing the risk of exacerbating hyperkalemia with the continued use of Lisinopril, an ACE inhibitor.

In response to these developments, the interdisciplinary team prioritizes interventions aimed at stabilizing the patient's condition. A fluid management strategy is implemented, involving cautious diuretic therapy to reduce fluid overload, while monitoring renal function closely. Kayexalate is considered to address hyperkalemia. The patient is educated on the importance of dietary modifications to manage fluid and electrolyte levels. This clinical scenario underscores the complexity of managing acute kidney injury superimposed on chronic kidney disease, requiring continuous assessment and adjustment of treatment plans to mitigate risks and prevent further complications.

Section 2

Response to Interventions:

Following the initiation of the fluid management strategy and careful administration of diuretics, the nursing team observes gradual improvement in the patient's symptoms. The patient's vital signs show a slight decrease in blood pressure to 155/95 mmHg, and heart rate stabilizes at 100 bpm. Oxygen saturation improves to 93% with supplemental oxygen, suggesting a reduction in pulmonary congestion. However, the patient continues to exhibit signs of confusion, albeit less severe, indicating that uremic encephalopathy may still be present but showing initial signs of improvement.

Laboratory results post-intervention reveal a modest decrease in serum potassium levels, now at 5.8 mmol/L, after the administration of Kayexalate. This suggests a positive response to the intervention aimed at managing hyperkalemia. However, renal function markers such as serum creatinine and blood urea nitrogen remain elevated, highlighting the ongoing challenge of managing acute kidney injury in the context of chronic kidney disease. Electrolyte monitoring shows persistent mild hyponatremia, which requires continued attention to fluid and sodium intake.

Despite these encouraging signs, the patient develops a new onset of muscle weakness and occasional palpitations, raising concerns about possible hypocalcemia or the effects of electrolyte shifts. A comprehensive review of the patient's medication regimen is undertaken to identify any agents that may contribute to electrolyte disturbances. The interdisciplinary team emphasizes the importance of ongoing monitoring and adjustment of the treatment plan, recognizing the complexity of the patient's condition and the potential for further complications. These developments necessitate close observation and a dynamic approach to care, ensuring interventions are tailored to the patient's evolving clinical status.

Section 3

New Diagnostic Results

As the healthcare team continues to manage the patient's condition, new diagnostic results provide further insight into the underlying complications. An ECG is performed to investigate the reported palpitations and reveals occasional premature ventricular contractions (PVCs), likely exacerbated by the ongoing electrolyte imbalances. A follow-up serum calcium test is conducted, confirming hypocalcemia with a value of 7.8 mg/dL. This finding correlates with the patient's muscle weakness and suggests the need for calcium supplementation and careful monitoring of cardiac function.

Additionally, repeat renal function tests show a slight improvement in serum creatinine, now at 3.4 mg/dL, down from previous levels, indicating a gradual yet positive response to fluid management and diuretic therapy. However, blood urea nitrogen remains elevated at 64 mg/dL, underscoring the persistent challenge of managing the patient's chronic kidney disease. Liver function tests are also checked to rule out additional complications, with results falling within normal ranges, thus helping to narrow the potential causes of the patient's symptoms.

These diagnostic findings prompt the healthcare team to adjust the treatment plan. Calcium supplements are added to address hypocalcemia, while the patient's diuretic regimen is reviewed to prevent further electrolyte disturbances. The interdisciplinary team discusses the importance of maintaining a delicate balance between fluid management and electrolyte stabilization, emphasizing the need for regular monitoring and timely intervention. This proactive approach aims to mitigate the risk of further complications, ensuring that the patient receives comprehensive and responsive care as they continue their recovery journey.

Section 4

As the treatment plan is adjusted to address the hypocalcemia, the healthcare team monitors the patient's response to the newly introduced calcium supplements. Over the next 48 hours, there is a notable improvement in the patient's muscle strength and a reduction in the frequency of palpitations, indicating a positive response to the calcium supplementation. However, during a routine assessment, the patient reports experiencing increased shortness of breath and mild chest discomfort. Vital signs reveal a blood pressure of 150/92 mmHg, heart rate of 96 beats per minute, respiratory rate of 22 breaths per minute, and oxygen saturation of 93% on room air. These findings suggest a potential fluid overload, likely a consequence of the delicate balance needed between diuretic therapy and fluid management in the context of their chronic kidney disease.

In light of these new symptoms, a chest X-ray is performed, revealing mild pulmonary congestion, which confirms the suspicion of fluid overload. The healthcare team decides to modify the patient's diuretic regimen, opting for a loop diuretic with a more potent action to help alleviate the excess fluid. This adjustment aims to reduce the risk of pulmonary edema while carefully monitoring electrolyte levels to prevent further imbalances. Concurrently, the team initiates low-flow supplemental oxygen therapy to improve the patient's oxygen saturation and ease respiratory distress.

As the patient progresses, the interdisciplinary team remains vigilant, recognizing the intricate interplay between fluid balance, electrolyte homeostasis, and cardiovascular stability. They emphasize the importance of regular follow-up assessments and lab tests to closely monitor renal function, electrolyte levels, and cardiac status. The team discusses the potential for future renal replacement therapy if the patient's kidney function does not stabilize, highlighting the need for comprehensive planning and patient education to empower the patient in managing their condition. This strategic approach aims to optimize the patient's recovery and prevent the onset of further complications, marking a crucial step in their ongoing care journey.

Section 5

New Complications:

Despite the initial positive response to the adjusted diuretic regimen and supplemental oxygen therapy, the patient begins to exhibit signs of renal function deterioration over the next 72 hours. Laboratory tests reveal an increase in serum creatinine levels to 2.8 mg/dL from a prior 2.3 mg/dL, along with a blood urea nitrogen (BUN) level of 48 mg/dL. These findings suggest a worsening of the acute kidney injury (AKI), raising concerns about the patient's ability to manage fluid and electrolyte balance effectively. Additionally, electrolyte panels show a drop in serum potassium to 3.2 mEq/L, prompting the healthcare team to consider the potential impact of the increased diuretic dosage on electrolyte depletion.

The patient also reports experiencing new episodes of dizziness and lightheadedness, which are corroborated by orthostatic hypotension observed during physical examination; blood pressure readings drop to 130/88 mmHg when moving from a supine to standing position. The combination of hypokalemia and orthostatic changes indicates a need for careful reassessment of the treatment strategy, particularly balancing the management of fluid overload while preventing further electrolyte imbalances. These complications necessitate a multidisciplinary discussion to explore potential adjustments to the diuretic therapy, alongside the introduction of potassium supplementation and possibly a more tailored fluid management plan.

Faced with these new challenges, the healthcare team emphasizes the importance of individualized care, considering the patient's unique presentation and evolving clinical picture. They discuss the potential need for closer monitoring in a step-down unit to ensure timely intervention should the patient's condition continue to decline. The team also underscores the importance of reinforcing patient education regarding dietary modifications, fluid restrictions, and recognizing early signs of electrolyte imbalances. By doing so, they aim to empower the patient to actively participate in their care and prevent further deterioration, setting the stage for the next phase of their treatment journey.